Resources

An unknown infectious agent is analyzed to determine its cellular nature. Chemical fractionation yields a macromolecular composition of exactly 48.0% protein48.0\%\text{ protein}, 12.0% lipid12.0\%\text{ lipid}, and 40.0% nucleic acid40.0\%\text{ nucleic acid} by mass. Quantitative enzymatic assays reveal that the agent completely lacks diaminopimelic acid, NN-acetylmuramic acid, and ATP synthase activity, but contains a reverse transcriptase enzyme (Mr≈71 kDaM_r \approx 71\text{ kDa}). Furthermore, incubation with 100 μg/mL100\,\mu\text{g/mL} tetracycline (30S30\text{S} ribosomal subunit inhibitor) causes 0%0\% inhibition of macromolecular synthesis, whereas 5.0 μM5.0\,\mu\text{M} zidovudine (AZT, a thymidine analogue) reduces nucleic acid elongation by 92.5%92.5\%. Deduce whether this unknown agent is a bacterium or an enveloped virus, providing three independent lines of biochemical evidence from the data.

Answer and steps

Final answer

The unknown agent is an enveloped virus (specifically a retrovirus). Evidence: (1) Absence of NN-acetylmuramic acid and diaminopimelic acid demonstrates the complete absence of a bacterial peptidoglycan wall; (2) Total lack of ATP synthase and presence of reverse transcriptase signify acellular non-metabolizing architecture and viral replication; (3) Insensitivity to tetracycline demonstrates the absence of bacterial 70S70\text{S} (30S30\text{S} subunit) ribosomes, while profound inhibition by zidovudine (AZT) confirms dependence on reverse transcription.

Steps

01

Structural and Cell Wall Composition

To determine whether the unknown infectious agent is a bacterium or an enveloped virus, we evaluate the structural, metabolic, and pharmacological data against the defining characteristics of each entity:

  • Observation: The agent contains 12.0%12.0\% lipid by mass, showing the presence of a lipid membrane, but completely lacks NN-acetylmuramic acid (NAM\text{NAM}) and diaminopimelic acid (DAP\text{DAP}).
  • Biological Principle: Peptidoglycan (murein) forms the structural backbone of bacterial cell walls, consisting of alternating β-(1,4)\beta\text{-(1,4)}-linked NN-acetylglucosamine (NAG\text{NAG}) and NN-acetylmuramic acid (NAM\text{NAM}) cross-linked by short peptide stems (which typically incorporate diaminopimelic acid in Gram-negative bacteria or specific Gram-positive variants).
  • Deduction: The total absence of NAM\text{NAM} and DAP\text{DAP} rules out a bacterial cell wall. The lipid fraction (12.0%12.0\%) instead corresponds to a viral lipid bilayer envelope derived from host cell membranes.
02

Metabolic Machinery and Enzymatic Profile

  • Observation: The agent possesses 0%0\% ATP synthase activity, but contains a functional reverse transcriptase enzyme (Mr≈71 kDaM_r \approx 71\text{ kDa}).
  • Biological Principle: Bacteria are autonomous cellular organisms that generate their own electrochemical gradients to synthesize ATP via membrane-bound ATP synthase complexes. Viruses are acellular and metabolically inert; they lack independent energy-generating systems. Furthermore, reverse transcriptase is an enzyme characteristic of retroviruses (such as HIV), used to transcribe viral single-stranded RNA into complementary DNA.
  • Deduction: The lack of independent energy-generating enzymes (ATP synthase) confirms an acellular structure, while the presence of reverse transcriptase specifically indicates a retrovirus.
03

Response to Targeted Antimicrobial and Antiviral Agents

  • Observation: Incubation with tetracycline yields 0%0\% inhibition of macromolecular synthesis, whereas zidovudine (AZT) causes a 92.5%92.5\% reduction in nucleic acid elongation.
  • Biological Principle:
    • Tetracycline is a broad-spectrum antibiotic that binds reversibly to the 30S30\text{S} subunit of bacterial 70S70\text{S} ribosomes, blocking aminoacyl-tRNA attachment and arresting bacterial translation.
    • Zidovudine (AZT) is an antiretroviral nucleoside analogue (specifically an azido-substituted thymidine analogue) that acts as an obligate chain terminator during viral reverse transcription because it lacks a 3′-OH3'\text{-OH} group.
  • Deduction: Complete insensitivity to tetracycline proves the absence of functional bacterial ribosomes, while potent inhibition by AZT confirms that replication depends on reverse transcription.

Conclusion

Based on these three independent lines of evidence—absence of peptidoglycan components, lack of ATP-generating machinery combined with the presence of reverse transcriptase, and selective inhibition by an antiretroviral rather than an antibacterial agent—the agent is an enveloped virus (specifically a retrovirus).

Typical errors

OverviewACEpath Teacher's Diagnosis

01 A student misinterprets the 12% lipid content and susceptibility to zidovudine as indicative of a bacterium with a plasma membrane, erroneously classifying it as an atypical bacterium.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    Lipid content of 12.0%12.0\% indicates the presence of a Chlamydia phospholipid cell membrane.

    Correct

    A lipid content of 12.0%12.0\% in an acellular agent indicates a viral lipoprotein envelope derived from host membranes rather than an autonomous bacterial plasma membrane.

    You noted the presence of lipids, but enveloped viruses also contain a lipid bilayer membrane acquired from host cellular membranes during budding.

  2. Step 2

    Lack of diaminopimelic acid and N-acetylmuramic acid means it is a wall-less bacterium like Mycoplasma.

    Correct

    The complete absence of NN-acetylmuramic acid (NAM) and diaminopimelic acid (DAP) confirms the absence of a peptidoglycan cell wall, pointing toward an acellular entity rather than an atypical bacterium.

    While Mycoplasma lacks peptidoglycan, an organism that also completely lacks ATP synthase and contains reverse transcriptase cannot be an autonomous bacterium.

  3. Step 3

    AZT inhibits DNA replication, showing active bacterial nucleic acid synthesis.

    Correct

    Zidovudine (AZT) is an antiretroviral thymidine analogue that selectively terminates cDNA elongation by reverse transcriptase; combined with 0%0\% inhibition by the bacterial ribosome inhibitor tetracycline, this demonstrates a viral replication mechanism.

    AZT specifically targets retroviral reverse transcriptase over bacterial DNA polymerases, and complete insensitivity to tetracycline confirms the absence of bacterial 70S70\text{S} ribosomes.

  4. Step 4

    Therefore, the unknown agent is a bacterium.

    Correct

    Therefore, the unknown infectious agent is an enveloped virus (specifically a retrovirus).

    Because the agent lacks metabolic machinery (ATP synthase), contains reverse transcriptase, resists antibacterial protein synthesis inhibitors, and is blocked by an antiretroviral chain terminator, it is an enveloped virus.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified that the lipid fraction reflects a lipid bilayer membrane.

You recognized that NN-acetylmuramic acid and diaminopimelic acid are diagnostic components of bacterial peptidoglycan.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Misclassification of Viral vs. Bacterial Biomarkers

You rationalized individual negative findings using exceptions in bacteriology (such as Mycoplasma) instead of evaluating the collective profile of metabolic dormancy, reverse transcriptase, and pharmacological response.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

Confusing viral envelopes with bacterial plasma membranes and overlooking that targeted pharmacological responses (AZT susceptibility vs. tetracycline resistance) and acellular metabolic dormancy (absence of ATP synthase) rule out autonomous cellular organisms.

REASONING PATH
Your ACEpath teacher’s suggested approach
Acellular Nature vs. Cellular Autonomy
  • Bacteria possess autonomous metabolic machinery (such as ATP synthase and 70S70\text{S} ribosomes), whereas viruses are acellular and lack independent energy-generating systems.

  • Always verify whether the agent possesses ATP generation and translation machinery before attributing membranes to cellular life.

Pharmacological Profiling
  • Antibiotics targeting translation (e.g., tetracycline on 30S30\text{S} subunits) inhibit bacteria, while nucleoside reverse transcriptase inhibitors (e.g., AZT) selectively inhibit retroviruses.

  • Use antibiotic and antiviral sensitivity assays as mutually exclusive confirmation of cellular vs. viral replication machinery.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. The absence of NAM and DAP confirms no peptidoglycan cell wall is present, meaning the 12.0%12.0\% lipid fraction represents a viral envelope.

  2. The absence of ATP synthase shows a complete lack of metabolic autonomy, while the presence of a 71 kDa71\text{ kDa} reverse transcriptase is a hallmark of retroviruses.

  3. Tetracycline (30S30\text{S} ribosomal inhibitor) shows 0%0\% inhibition, proving the absence of bacterial ribosomes, while AZT causes 92.5%92.5\% inhibition, confirming reverse transcription.

Final answer

The unknown agent is an enveloped virus (retrovirus).

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the macromolecular and enzymatic differences between autonomous cellular bacteria and acellular enveloped viruses.

  • Practice correlating targeted antimicrobial mechanisms (e.g., cell wall and ribosome inhibitors) and antiviral mechanisms (e.g., reverse transcriptase inhibitors) with specific pathogen classes.

OverviewACEpath Teacher's Diagnosis

02 A student incorrectly concludes the agent is a non-enveloped virus because they misinterpret the 12% lipid fraction as host contaminant rather than an integral envelope.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    The lack of peptidoglycan markers and lack of ATP synthase confirm a viral nature.

  2. Step 2

    Susceptibility to AZT and presence of reverse transcriptase indicate a retrovirus.

  3. Step 3

    The 12.0%12.0\% lipid is background cellular debris rather than a membrane.

    Correct

    A macromolecular composition of 12.0%12.0\% lipid by mass represents an integral lipid bilayer envelope derived from host cell membranes, distinguishing an enveloped virus from a naked (non-enveloped) nucleocapsid.

    In quantitative fractionation of purified virions, an integral lipid fraction (here 12.0%12.0\%) indicates a viral lipid envelope. Non-enveloped viruses consist almost entirely of protein and nucleic acid with approximately 0%0\% lipid.

  4. Step 4

    Therefore, the agent is a non-enveloped virus.

    Correct

    Therefore, the unknown agent is an enveloped virus (specifically a retrovirus).

    Because you misinterpreted the 12.0%12.0\% lipid as contaminant debris rather than structural membrane, your final classification became non-enveloped instead of enveloped.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly deduced that the absence of peptidoglycan markers and ATP synthase rules out a bacterial identity.

You accurately identified the presence of reverse transcriptase and inhibition by AZT as hallmarks of a retrovirus.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Lipid Fraction Misinterpretation

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You treated the purified 12.0%12.0\% lipid fraction as experimental artifact or background debris rather than the structural hallmark of a viral envelope.

REASONING PATH
Your ACEpath teacher’s suggested approach
Macromolecular Composition of Viruses
  • Purified non-enveloped (naked) viruses consist solely of protein and nucleic acid (≈0% lipid{\approx}0\%\text{ lipid}). Enveloped viruses contain a host-derived lipid bilayer envelope (10%–35% lipid by mass10\%\text{--}35\%\text{ lipid by mass}).

  • When a purified infectious agent contains a substantial lipid fraction (≥10%{\ge}10\% by mass) without bacterial peptidoglycan or independent metabolism, classify it as an enveloped virus.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Recognize that a macromolecular composition of 12.0% lipid12.0\%\text{ lipid}, 48.0% protein48.0\%\text{ protein}, and 40.0% nucleic acid40.0\%\text{ nucleic acid} reflects the structural components of an intact virion: a lipid bilayer envelope containing viral glycoproteins surrounding a protein capsid and nucleic acid genome.

  2. Conclude that the presence of an integral lipid envelope, combined with the lack of bacterial cell-wall polymers and presence of retroviral reverse transcriptase, defines the agent as an enveloped virus.

Final answer

The unknown agent is an enveloped virus (specifically a retrovirus).

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the structural differences between naked capsids and enveloped viruses, paying close attention to their macromolecular percentages by dry mass.

  • Practice distinguishing experimental artifacts from true compositional data when analyzing quantitative macromolecular fractionation results.

Lock it in

Similar question

01

A newly discovered pathogen contains genomic DNA, 62%62\% protein, and 28%28\% lipid by mass. It is completely resistant to penicillin and ampicillin, but its growth is arrested by erythromycin (a 50S50\text{S} ribosomal subunit inhibitor), and it generates a measurable transmembrane proton gradient. Classify this organism and explain the resistance to beta-lactams.

Answer

The organism is a bacterium (specifically a cell wall-less bacterium such as Mycoplasma). Key steps: (1) It exhibits autonomous metabolism (proton gradient); (2) Sensitivity to erythromycin proves functional bacterial 70S70\text{S} ribosomes; (3) Resistance to beta-lactams occurs because it naturally lacks peptidoglycan (the target of penicillin).

02

An isolate contains single-stranded RNA and has a lipid-to-protein mass ratio of 1:41:4. Chemical analysis detects no muramic acid, no teichoic acid, and no DNA-dependent RNA polymerase. It is unaffected by ciprofloxacin (a bacterial DNA gyrase inhibitor), but its propagation is blocked by remdesivir. Deduce whether the agent is a bacterium, an enveloped virus, or a non-enveloped virus.

Answer

The isolate is an enveloped virus. Key steps: (1) Lipids without cell wall components (muramic acid/teichoic acid) denote a viral envelope; (2) Lack of metabolic and transcription machinery combined with insensitivity to a bacterial topoisomerase inhibitor (ciprofloxacin) rules out bacteria; (3) Blockage by remdesivir (an RNA-dependent RNA polymerase inhibitor) confirms an RNA virus with a membrane.

03

Two filterable infectious fractions (Sample X and Sample Y) are analyzed. Fraction X contains NN-acetylglucosamine, D-alanine, and exhibits respiration upon glucose addition. Fraction Y completely lacks respiratory activity, contains integrase, and is inhibited by raltegravir but not chloramphenicol. Identify the nature of both samples and contrast their methods of macromolecule synthesis.

Answer

Sample X is a bacterium; Sample Y is an enveloped retrovirus. Key steps: (1) Sample X displays active respiration and peptidoglycan building blocks (D-alanine, NAG), indicating autonomous cellular metabolism and bacterial cell wall synthesis; (2) Sample Y lacks independent respiration, contains integrase, and responds to an integrase inhibitor (raltegravir) rather than a ribosomal inhibitor (chloramphenicol); (3) Sample X synthesizes its own macromolecules using bacterial enzymes and 70S70\text{S} ribosomes, whereas Sample Y depends entirely on host cell ribosomes and metabolic energy.

Loading workspace…